Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 105 entries
Sorted by: Best Match Show Resources per page
[Rehabilitation after heart infarct].

Nederlands tijdschrift voor geneeskunde

Meijler FL.
PMID: 4786629
Ned Tijdschr Geneeskd. 1973 Aug 18;117(33):1234-6.

No abstract available.

Cite
Meijler FL. Revalidatie na hartinfarct. [Rehabilitation after heart infarct]. Ned Tijdschr Geneeskd. 1973;117(33):1234-6
Meijler, F. L. (1973). Revalidatie na hartinfarct. [Rehabilitation after heart infarct]. Nederlands tijdschrift voor geneeskunde, 117(33), 1234-6.
Meijler, F L. "Revalidatie na hartinfarct." [Rehabilitation after heart infarct]. Nederlands tijdschrift voor geneeskunde vol. 117,33 (1973): 1234-6.
Meijler FL. Revalidatie na hartinfarct. [Rehabilitation after heart infarct]. Ned Tijdschr Geneeskd. 1973 Aug 18;117(33):1234-6. Dutch. PMID: 4786629.
Copy Download .nbib Format: NLM
Erratum to: Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.

Surgical endoscopy

Schölvinck DW, Künzli HT, Meijer SL, Seldenrijk CA, van Berge Henegouwen MI, Bergman JJ, Weusten BL.
PMID: 27488461
Surg Endosc. 2016 Sep;30(9):4114. doi: 10.1007/s00464-016-5147-8.

No abstract available.

Cite
Schölvinck DW, Künzli HT, Meijer SL, et al. Erratum to: Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016;30(9):4114doi: 10.1007/s00464-016-5147-8.
Schölvinck, D. W., Künzli, H. T., Meijer, S. L., Seldenrijk, C. A., van Berge Henegouwen, M. I., Bergman, J. J., & Weusten, B. L. (2016). Erratum to: Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surgical endoscopy, 30(9), 4114. https://doi.org/10.1007/s00464-016-5147-8
Schölvinck, D W, et al. "Erratum to: Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease." Surgical endoscopy vol. 30,9 (2016): 4114. doi: https://doi.org/10.1007/s00464-016-5147-8
Schölvinck DW, Künzli HT, Meijer SL, Seldenrijk CA, van Berge Henegouwen MI, Bergman JJ, Weusten BL. Erratum to: Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016 Sep;30(9):4114. doi: 10.1007/s00464-016-5147-8. PMID: 27488461.
Copy Download .nbib Format: NLM
Alternative equilibria in shallow lakes.

Trends in ecology & evolution

Scheffer M, Hosper SH, Meijer ML, Moss B, Jeppesen E.
PMID: 21236168
Trends Ecol Evol. 1993 Aug;8(8):275-9. doi: 10.1016/0169-5347(93)90254-M.

The turbidity of lakes is generally considered to be a smooth function of their nutrient status. However, recent results suggest that over a range of nutrient concentrations, shallow lakes can have two alternative equilibria: a clear state dominated by...

Cite
Scheffer M, Hosper SH, Meijer ML, et al. Alternative equilibria in shallow lakes. Trends Ecol Evol. 1993;8(8):275-9doi: 10.1016/0169-5347(93)90254-M.
Scheffer, M., Hosper, S. H., Meijer, M. L., Moss, B., & Jeppesen, E. (1993). Alternative equilibria in shallow lakes. Trends in ecology & evolution, 8(8), 275-9. https://doi.org/10.1016/0169-5347(93)90254-M
Scheffer, M, et al. "Alternative equilibria in shallow lakes." Trends in ecology & evolution vol. 8,8 (1993): 275-9. doi: https://doi.org/10.1016/0169-5347(93)90254-M
Scheffer M, Hosper SH, Meijer ML, Moss B, Jeppesen E. Alternative equilibria in shallow lakes. Trends Ecol Evol. 1993 Aug;8(8):275-9. doi: 10.1016/0169-5347(93)90254-M. PMID: 21236168.
Copy Download .nbib Format: NLM
Synthesis of New N,N'-Bis(5-arylidene-4-oxo-4,5-dihydrothiazolin-2-yl)piperazine Derivatives Under Microwave Irradiation and Preliminary Biological Evaluation.

Scientia pharmaceutica

Coulibaly WK, Paquin L, Bénié A, Bekro YA, Durieux E, Meijer L, Le Guével R, Corlu A, Bazureau JP.
PMID: 23264934
Sci Pharm. 2012 Oct-Dec;80(4):825-36. doi: 10.3797/scipharm.1206-04. Epub 2012 Sep 16.

New N,N'-bis(5-arylidene-4-oxo-4,5-dihydrothiazoline-2-yl)diamine derivatives 5 were prepared in two steps from rhodanine and piperazine, or 1,4-bis(3-amino-propyl)piperazine, under microwave reaction conditions with retention of configuration. Some of these compounds were tested for in vitro antiproliferative activities and for their kinase inhibitory...

Cite
Coulibaly WK, Paquin L, Bénié A, et al. Synthesis of New N,N'-Bis(5-arylidene-4-oxo-4,5-dihydrothiazolin-2-yl)piperazine Derivatives Under Microwave Irradiation and Preliminary Biological Evaluation. Sci Pharm. 2012;80(4):825-36doi: 10.3797/scipharm.1206-04.
Coulibaly, W. K., Paquin, L., Bénié, A., Bekro, Y. A., Durieux, E., Meijer, L., Le Guével, R., Corlu, A., & Bazureau, J. P. (2012). Synthesis of New N,N'-Bis(5-arylidene-4-oxo-4,5-dihydrothiazolin-2-yl)piperazine Derivatives Under Microwave Irradiation and Preliminary Biological Evaluation. Scientia pharmaceutica, 80(4), 825-36. https://doi.org/10.3797/scipharm.1206-04
Coulibaly, Wacothon Karime, et al. "Synthesis of New N,N'-Bis(5-arylidene-4-oxo-4,5-dihydrothiazolin-2-yl)piperazine Derivatives Under Microwave Irradiation and Preliminary Biological Evaluation." Scientia pharmaceutica vol. 80,4 (2012): 825-36. doi: https://doi.org/10.3797/scipharm.1206-04
Coulibaly WK, Paquin L, Bénié A, Bekro YA, Durieux E, Meijer L, Le Guével R, Corlu A, Bazureau JP. Synthesis of New N,N'-Bis(5-arylidene-4-oxo-4,5-dihydrothiazolin-2-yl)piperazine Derivatives Under Microwave Irradiation and Preliminary Biological Evaluation. Sci Pharm. 2012 Oct-Dec;80(4):825-36. doi: 10.3797/scipharm.1206-04. Epub 2012 Sep 16. PMID: 23264934; PMCID: PMC3528043.
Copy Download .nbib Format: NLM
Proteome-wide mapping of PQS-interacting proteins in .

Chemical science

Dandela R, Mantin D, Cravatt BF, Rayo J, Meijler MM.
PMID: 29719702
Chem Sci. 2018 Jan 19;9(8):2290-2294. doi: 10.1039/c7sc04287f. eCollection 2018 Feb 28.

The opportunistic human pathogen

Cite
Dandela R, Mantin D, Cravatt BF, et al. Proteome-wide mapping of PQS-interacting proteins in . Chem Sci. 2018;9(8):2290-2294doi: 10.1039/c7sc04287f.
Dandela, R., Mantin, D., Cravatt, B. F., Rayo, J., & Meijler, M. M. (2018). Proteome-wide mapping of PQS-interacting proteins in . Chemical science, 9(8), 2290-2294. https://doi.org/10.1039/c7sc04287f
Dandela, Rambabu, et al. "Proteome-wide mapping of PQS-interacting proteins in ." Chemical science vol. 9,8 (2018): 2290-2294. doi: https://doi.org/10.1039/c7sc04287f
Dandela R, Mantin D, Cravatt BF, Rayo J, Meijler MM. Proteome-wide mapping of PQS-interacting proteins in . Chem Sci. 2018 Jan 19;9(8):2290-2294. doi: 10.1039/c7sc04287f. eCollection 2018 Feb 28. PMID: 29719702; PMCID: PMC5897874.
Copy Download .nbib Format: NLM
Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors.

Cancers

Meijer LL, Puik JR, Le Large TYS, Heger M, Dijk F, Funel N, Wurdinger T, Garajová I, van Grieken NCT, van de Wiel MA, Giovannetti E, Kazemier G.
PMID: 31443224
Cancers (Basel). 2019 Aug 15;11(8). doi: 10.3390/cancers11081181.

Accurate diagnosis of pancreatic head lesions remains challenging as no minimally invasive biomarkers are available to discriminate distal cholangiocarcinoma (CCA) from pancreatic ductal adenocarcinoma (PDAC). The aim of this study is to identify specific circulating microRNAs (miRNAs) to diagnose...

Cite
Meijer LL, Puik JR, Le Large TYS, et al. Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors. Cancers (Basel). 2019;11(8)doi: 10.3390/cancers11081181.
Meijer, L. L., Puik, J. R., Le Large, T. Y. S., Heger, M., Dijk, F., Funel, N., Wurdinger, T., Garajová, I., van Grieken, N. C. T., van de Wiel, M. A., Giovannetti, E., & Kazemier, G. (2019). Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors. Cancers, 11(8), . https://doi.org/10.3390/cancers11081181
Meijer, Laura L, et al. "Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors." Cancers vol. 11,8 (2019). doi: https://doi.org/10.3390/cancers11081181
Meijer LL, Puik JR, Le Large TYS, Heger M, Dijk F, Funel N, Wurdinger T, Garajová I, van Grieken NCT, van de Wiel MA, Giovannetti E, Kazemier G. Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors. Cancers (Basel). 2019 Aug 15;11(8). doi: 10.3390/cancers11081181. PMID: 31443224; PMCID: PMC6721566.
Copy Download .nbib Format: NLM
Sublingual sufentanil for postoperative pain relief: first clinical experiences.

Journal of pain research

Meijer F, Cornelissen P, Sie C, Wagemans M, Mars A, Hobma T, Niesters M, Dahan A, Koopman JS, Steegers MA.
PMID: 29872335
J Pain Res. 2018 May 24;11:987-992. doi: 10.2147/JPR.S160091. eCollection 2018.

BACKGROUND: The sublingual sufentanil tablet system (SSTS) is a novel hand-held patient-controlled analgesia device developed for treatment of moderate-to-severe postoperative pain. Here we present the first results of its clinical use.METHODS: Adult patients undergoing major surgery in five hospitals...

Cite
Meijer F, Cornelissen P, Sie C, et al. Sublingual sufentanil for postoperative pain relief: first clinical experiences. J Pain Res. 2018;11:987-992doi: 10.2147/JPR.S160091.
Meijer, F., Cornelissen, P., Sie, C., Wagemans, M., Mars, A., Hobma, T., Niesters, M., Dahan, A., Koopman, J. S., & Steegers, M. A. (2018). Sublingual sufentanil for postoperative pain relief: first clinical experiences. Journal of pain research, 11987-992. https://doi.org/10.2147/JPR.S160091
Meijer, Fleur, et al. "Sublingual sufentanil for postoperative pain relief: first clinical experiences." Journal of pain research vol. 11 (2018): 987-992. doi: https://doi.org/10.2147/JPR.S160091
Meijer F, Cornelissen P, Sie C, Wagemans M, Mars A, Hobma T, Niesters M, Dahan A, Koopman JS, Steegers MA. Sublingual sufentanil for postoperative pain relief: first clinical experiences. J Pain Res. 2018 May 24;11:987-992. doi: 10.2147/JPR.S160091. eCollection 2018. PMID: 29872335; PMCID: PMC5973446.
Copy Download .nbib Format: NLM
Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?.

Critical reviews in oncology/hematology

Meijer LL, Zwart ES, Brandt BW, Mebius R, Deng D, Giovannetti E, Zaura E, Kazemier G.
PMID: 31731215
Crit Rev Oncol Hematol. 2019 Dec;144:102824. doi: 10.1016/j.critrevonc.2019.102824. Epub 2019 Nov 02.

No abstract available.

Cite
Meijer LL, Zwart ES, Brandt BW, et al. Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?. Crit Rev Oncol Hematol. 2019;144:102824doi: 10.1016/j.critrevonc.2019.102824.
Meijer, L. L., Zwart, E. S., Brandt, B. W., Mebius, R., Deng, D., Giovannetti, E., Zaura, E., & Kazemier, G. (2019). Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?. Critical reviews in oncology/hematology, 144102824. https://doi.org/10.1016/j.critrevonc.2019.102824
Meijer, Laura L, et al. "Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?." Critical reviews in oncology/hematology vol. 144 (2019): 102824. doi: https://doi.org/10.1016/j.critrevonc.2019.102824
Meijer LL, Zwart ES, Brandt BW, Mebius R, Deng D, Giovannetti E, Zaura E, Kazemier G. Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?. Crit Rev Oncol Hematol. 2019 Dec;144:102824. doi: 10.1016/j.critrevonc.2019.102824. Epub 2019 Nov 02. PMID: 31731215.
Copy Download .nbib Format: NLM
Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study.

Biomedical optics express

Jelvehgaran P, Alderliesten T, Georgiou G, Meijer SL, Bloemen PR, Kodach LL, van Laarhoven HWM, van Berge Henegouwen MI, Hulshof MCCM, Rasch CRN, van Leeuwen TG, de Boer JF, de Bruin M, van Herk M.
PMID: 30615728
Biomed Opt Express. 2018 Aug 14;9(9):4196-4216. doi: 10.1364/BOE.9.004196. eCollection 2018 Sep 01.

Treatment of resectable esophageal cancer includes neoadjuvant chemo-radiation therapy (nCRT) followed by esophagectomy in operable patients. High-risk surgery may have been avoided in patients with a pathological complete response (pCR). We investigated the feasibility of optical coherence tomography (OCT)...

Cite
Jelvehgaran P, Alderliesten T, Georgiou G, et al. Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study. Biomed Opt Express. 2018;9(9):4196-4216doi: 10.1364/BOE.9.004196.
Jelvehgaran, P., Alderliesten, T., Georgiou, G., Meijer, S. L., Bloemen, P. R., Kodach, L. L., van Laarhoven, H. W. M., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Rasch, C. R. N., van Leeuwen, T. G., de Boer, J. F., de Bruin, M., & van Herk, M. (2018). Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study. Biomedical optics express, 9(9), 4196-4216. https://doi.org/10.1364/BOE.9.004196
Jelvehgaran, Pouya, et al. "Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study." Biomedical optics express vol. 9,9 (2018): 4196-4216. doi: https://doi.org/10.1364/BOE.9.004196
Jelvehgaran P, Alderliesten T, Georgiou G, Meijer SL, Bloemen PR, Kodach LL, van Laarhoven HWM, van Berge Henegouwen MI, Hulshof MCCM, Rasch CRN, van Leeuwen TG, de Boer JF, de Bruin M, van Herk M. Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study. Biomed Opt Express. 2018 Aug 14;9(9):4196-4216. doi: 10.1364/BOE.9.004196. eCollection 2018 Sep 01. PMID: 30615728; PMCID: PMC6157785.
Copy Download .nbib Format: NLM
Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases.

United European gastroenterology journal

van der Wel MJ, Duits LC, Klaver E, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Tijssen JG, Bergman J, Meijer SL.
PMID: 30023060
United European Gastroenterol J. 2018 Jul;6(6):830-837. doi: 10.1177/2050640618764710. Epub 2018 Mar 07.

BACKGROUND: Dysplasia in Barrett's esophagus (BE) biopsies is associated with low observer agreement among general pathologists. Therefore, expert review is advised. We are developing a web-based, national expert review panel for histological review of BE biopsies.OBJECTIVE: The aim of...

Cite
van der Wel MJ, Duits LC, Klaver E, et al. Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases. United European Gastroenterol J. 2018;6(6):830-837doi: 10.1177/2050640618764710.
van der Wel, M. J., Duits, L. C., Klaver, E., Pouw, R. E., Seldenrijk, C. A., Offerhaus, G., Visser, M., Ten Kate, F., Tijssen, J. G., Bergman, J., & Meijer, S. L. (2018). Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases. United European gastroenterology journal, 6(6), 830-837. https://doi.org/10.1177/2050640618764710
van der Wel, M J, et al. "Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases." United European gastroenterology journal vol. 6,6 (2018): 830-837. doi: https://doi.org/10.1177/2050640618764710
van der Wel MJ, Duits LC, Klaver E, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Tijssen JG, Bergman J, Meijer SL. Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases. United European Gastroenterol J. 2018 Jul;6(6):830-837. doi: 10.1177/2050640618764710. Epub 2018 Mar 07. PMID: 30023060; PMCID: PMC6047285.
Copy Download .nbib Format: NLM
Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma.

United European gastroenterology journal

Künzli HT, Belghazi K, Pouw RE, Meijer SL, Seldenrijk CA, Weusten B, Bergman J.
PMID: 30083328
United European Gastroenterol J. 2018 Jun;6(5):669-677. doi: 10.1177/2050640617753808. Epub 2018 Jan 29.

INTRODUCTION: The risk of lymph node metastases (LNM) in submucosal esophageal adenocarcinoma (EAC) patients is subject to debate. These patients might be treated endoscopically if the risk of LNM appears to be low.OBJECTIVE: The objective of this article is...

Cite
Künzli HT, Belghazi K, Pouw RE, et al. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European Gastroenterol J. 2018;6(5):669-677doi: 10.1177/2050640617753808.
Künzli, H. T., Belghazi, K., Pouw, R. E., Meijer, S. L., Seldenrijk, C. A., Weusten, B., & Bergman, J. (2018). Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European gastroenterology journal, 6(5), 669-677. https://doi.org/10.1177/2050640617753808
Künzli, H T, et al. "Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma." United European gastroenterology journal vol. 6,5 (2018): 669-677. doi: https://doi.org/10.1177/2050640617753808
Künzli HT, Belghazi K, Pouw RE, Meijer SL, Seldenrijk CA, Weusten B, Bergman J. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European Gastroenterol J. 2018 Jun;6(5):669-677. doi: 10.1177/2050640617753808. Epub 2018 Jan 29. PMID: 30083328; PMCID: PMC6068782.
Copy Download .nbib Format: NLM
An inside look at a biofilm: .

Science advances

Ozer E, Yaniv K, Chetrit E, Boyarski A, Meijler MM, Berkovich R, Kushmaro A, Alfonta L.
PMID: 34117070
Sci Adv. 2021 Jun 11;7(24). doi: 10.1126/sciadv.abg8581. Print 2021 Jun.

The opportunistic pathogen,

Cite
Ozer E, Yaniv K, Chetrit E, et al. An inside look at a biofilm: . Sci Adv. 2021;7(24)doi: 10.1126/sciadv.abg8581.
Ozer, E., Yaniv, K., Chetrit, E., Boyarski, A., Meijler, M. M., Berkovich, R., Kushmaro, A., & Alfonta, L. (2021). An inside look at a biofilm: . Science advances, 7(24), . https://doi.org/10.1126/sciadv.abg8581
Ozer, Eden, et al. "An inside look at a biofilm: ." Science advances vol. 7,24 (2021). doi: https://doi.org/10.1126/sciadv.abg8581
Ozer E, Yaniv K, Chetrit E, Boyarski A, Meijler MM, Berkovich R, Kushmaro A, Alfonta L. An inside look at a biofilm: . Sci Adv. 2021 Jun 11;7(24). doi: 10.1126/sciadv.abg8581. Print 2021 Jun. PMID: 34117070; PMCID: PMC8195488.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 105 entries